Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Gestational Diabetes: Systematic Review and Meta-Analysis.

Nørgaard K, Sukumar N, Rafnsson SB, Saravanan P.

Diabetes Ther. 2018 Apr 5. doi: 10.1007/s13300-018-0411-7. [Epub ahead of print] Review.

PMID:
29623593
3.

Role of omalizumab in insulin hypersensitivity: a case report and review of the literature.

Mishra S, Connors L, Tugwell B.

Diabet Med. 2018 May;35(5):663-666. doi: 10.1111/dme.13591.

PMID:
29381818
4.

Use of 50/50 Premixed Insulin Analogs in Type 2 Diabetes: Systematic Review and Clinical Recommendations.

Deed G, Kilov G, Dunning T, Cutfield R, Overland J, Wu T.

Diabetes Ther. 2017 Dec;8(6):1265-1296. doi: 10.1007/s13300-017-0328-6. Epub 2017 Nov 7. Review.

5.

A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.

Heller S, White D, Lee E, Lawton J, Pollard D, Waugh N, Amiel S, Barnard K, Beckwith A, Brennan A, Campbell M, Cooper C, Dimairo M, Dixon S, Elliott J, Evans M, Green F, Hackney G, Hammond P, Hallowell N, Jaap A, Kennon B, Kirkham J, Lindsay R, Mansell P, Papaioannou D, Rankin D, Royle P, Smithson WH, Taylor C.

Health Technol Assess. 2017 Apr;21(20):1-278. doi: 10.3310/hta21200.

6.
7.

Different insulin types and regimens for pregnant women with pre-existing diabetes.

O'Neill SM, Kenny LC, Khashan AS, West HM, Smyth RM, Kearney PM.

Cochrane Database Syst Rev. 2017 Feb 3;2:CD011880. doi: 10.1002/14651858.CD011880.pub2. Review.

PMID:
28156005
8.

A Review of Insulin Degludec/Insulin Aspart: Pharmacokinetic and Pharmacodynamic Properties and Their Implications in Clinical Use.

Haahr H, Fita EG, Heise T.

Clin Pharmacokinet. 2017 Apr;56(4):339-354. doi: 10.1007/s40262-016-0455-7. Review.

9.

20 Years of insulin lispro in pediatric type 1 diabetes: a review of available evidence.

Kaiserman K, Jung H, Benabbad I, Karges B, Polak M, Rosilio M.

Pediatr Diabetes. 2017 Mar;18(2):81-94. doi: 10.1111/pedi.12401. Epub 2016 Jul 8. Review.

PMID:
27390032
10.

Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.

Fullerton B, Siebenhofer A, Jeitler K, Horvath K, Semlitsch T, Berghold A, Plank J, Pieber TR, Gerlach FM.

Cochrane Database Syst Rev. 2016 Jun 30;(6):CD012161. doi: 10.1002/14651858.CD012161. Review.

PMID:
27362975
11.

Systematic literature review of use of blood glucose monitoring in phase III clinical studies of insulin analogs.

Miikkulainen K, Caruso A, Mast O, Zhang R, Borisenko O.

BMC Endocr Disord. 2016 May 4;16(1):21. doi: 10.1186/s12902-016-0102-1. Review.

12.

Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis.

Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Gonzalez-Padilla DA.

Cochrane Database Syst Rev. 2016 Jan 21;(1):CD011281. doi: 10.1002/14651858.CD011281.pub2. Review.

PMID:
26798030
13.

Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence.

Bronsveld HK, ter Braak B, Karlstad Ø, Vestergaard P, Starup-Linde J, Bazelier MT, De Bruin ML, de Boer A, Siezen CL, van de Water B, van der Laan JW, Schmidt MK.

Breast Cancer Res. 2015 Aug 5;17:100. doi: 10.1186/s13058-015-0611-2.

14.

Forum for Injection Technique (FIT), India: The Indian recommendations 2.0, for best practice in Insulin Injection Technique, 2015.

Tandon N, Kalra S, Balhara YP, Baruah MP, Chadha M, Chandalia HB, Chowdhury S, Jothydev K, Kumar PK, V MS, Mithal A, Modi S, Pitale S, Sahay R, Shukla R, Sundaram A, Unnikrishnan AG, Wangnoo SK.

Indian J Endocrinol Metab. 2015 May-Jun;19(3):317-31. doi: 10.4103/2230-8210.152762. Review.

15.

Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics.

Pozzilli P, Battelino T, Danne T, Hovorka R, Jarosz-Chobot P, Renard E.

Diabetes Metab Res Rev. 2016 Jan;32(1):21-39. doi: 10.1002/dmrr.2653. Epub 2015 Jun 22. Review.

16.

Safety of insulin analogs during pregnancy: a meta-analysis.

Lv S, Wang J, Xu Y.

Arch Gynecol Obstet. 2015 Oct;292(4):749-56. doi: 10.1007/s00404-015-3692-3. Epub 2015 Apr 9. Review.

PMID:
25855052
17.

Clinical efficacy and safety of insulin aspart compared with regular human insulin in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis.

Wojciechowski P, Niemczyk-Szechowska P, Olewińska E, Jaros P, Mierzejewska B, Skarżyńska-Duk J, Małecki MT, Ryś P.

Pol Arch Med Wewn. 2015;125(3):141-51. Epub 2015 Jan 30. Review. Erratum in: Pol Arch Med Wewn. 2015;125(4):308.

18.

A comparison of biphasic insulin aspart and insulin glargine administered with oral antidiabetic drugs in type 2 diabetes mellitus--a systematic review and meta-analysis.

Rys P, Wojciechowski P, Siejka S, Małecki P, Hak L, Malecki MT.

Int J Clin Pract. 2014 Mar;68(3):304-13. doi: 10.1111/ijcp.12337. Epub 2014 Jan 28. Review.

PMID:
24471814
19.

Stability and performance of rapid-acting insulin analogs used for continuous subcutaneous insulin infusion: a systematic review.

Kerr D, Wizemann E, Senstius J, Zacho M, Ampudia-Blasco FJ.

J Diabetes Sci Technol. 2013 Nov 1;7(6):1595-606. Review.

20.

Diabetes, cancer and treatment - a mini-review.

Vestergaard P, Starup-Linde J.

Curr Drug Saf. 2013 Nov;8(5):292-5. Review.

PMID:
24215309

Supplemental Content

Loading ...
Support Center